Results 121 to 130 of about 589,938 (329)

Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease [PDF]

, 2014
Maria P. Martinez Cantarin, Scott W. Keith, Scott A. Waldman, Bonita Falkner   +3 more
openalex   +1 more source

Comorbidity Profiles among Obese–Diabetic End-Stage Renal Disease Patients: Data from REIN Registry of PACA Region of France

, 2021
Asmatullah Kakar, Yosra Mouelhi, Anderson Loundou, Adeline Crémades, Stéphanie Gentile   +4 more
openalex   +2 more sources

Serum uric acid and diabetic nephropathy. [PDF]

, 2012
Implication for health policy/practice/research/medical education: Diabetic nephropathy is the most common cause of end-stage renal disease worldwide.
Momeni, A.
core   +2 more sources

RNA‐Micelles as Self‐Assembling Structures for Efficient Co‐Delivery of Synergistic siRNA and Nucleoside Analogues to Treat CRC Lung Metastasis

Advanced Functional Materials, EarlyView.
Two kinds of self‐assembled RNA micelles were used to co‐deliver synergistic siRNA and nucleoside analogues for the treatment of colorectal cancer lung metastases. Near‐complete elimination of lung cancer metastases was confirmed in an orthotopic lung metastasis model constructed using human colorectal cancer lung metastases patient surgical samples to
Kai Jin, Piotr Rychahou, Daniel W. Binzel, B. Mark Evers, Peixuan Guo   +4 more
wiley   +1 more source

Association Between Starting Hemodialysis for End-Stage Renal Disease and Incident Cataract Surgery: A 12-Year Nationwide Cohort Study [PDF]

, 2016
Tyler Hyungtaek Rim, Chang-Yun Yoon, Hye Won Park, Eun Jee Chung   +3 more
openalex   +1 more source

PRELIVE: A Framework for Predicting Lipid Nanoparticles In Vivo Efficacy and Reducing Reliance on Animal Testing

Advanced Functional Materials, EarlyView.
PREdicting LNP In Vivo Efficacy (PRELIVE) framework enables the prediction of lipid nanoparticle (LNPs) organ‐specific delivery through dual modeling approaches. Composition‐based models using formulation parameters and protein corona‐based models using biological fingerprints both achieve high predictive accuracy across multiple organs.
Belal I. Hanafy, Chuan‐En Lu, Kai Liu, Audrey Gallud   +3 more
wiley   +1 more source

Chronic Constrictive Pericarditis in Association with End-Stage Renal Disease [PDF]

, 2011
Roman Leonid Kleynberg, Vera M. Kleynberg, Leonid Markus Kleynberg, Danny Farahmandian   +3 more
openalex   +1 more source

ENDOGENOUS DYSREGULATION OF THROMBOINFLAMMATORY BIOMARKERS IN END-STAGE RENAL DISEASE, AND THEIR AMPLIFICATION BY HEART FAILURE

, 2023
Vanessa Robbin, Vinod Bansal, Fakiha Siddiqui, Madeline T. Allen, Jawed Fareed, Mushabbar Syed   +5 more
openalex   +1 more source

Cost-effectiveness analysis of treatment for end-stage renal disease [PDF]

, 2010
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn Skoða/Opna(view/open)OBJECTIVE: End-stage renal disease (ESRD) requires costly life-sustaining therapy, either dialysis or kidney transplantation.
Eiríkur Jónsson, Gyða Ásmundsdóttir, María Heimisdóttir, Runólfur Pálsson,, Tinna Laufey Ásgeirsdóttir,   +4 more
core  

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source